- 专利标题: MODIFIED NK-92 CELLS FOR TREATING CANCER
-
申请号: EP24185893.5申请日: 2016-06-10
-
公开(公告)号: EP4424326A3公开(公告)日: 2024-11-13
- 发明人: LEE, Tien
- 申请人: ImmunityBio, Inc.
- 申请人地址: US Culver City, CA 90232 9920 Jefferson Boulevard
- 代理机构: Elkington and Fife LLP
- 优先权: US201662337044 P 20160516
- 主分类号: C12N5/0783
- IPC分类号: C12N5/0783 ; C07K14/54 ; C07K14/725 ; C07K14/735 ; C07K16/28 ; A61K35/17 ; A61K39/00 ; A61K39/395
摘要:
Provided herein are NK-92 cells expressing at least one CAR and at least one Fc receptor. Also provided are methods of treatment of a patient having or suspected of having a disease that is treatable with NK-92 cells, such as cancer, comprising administering to the patient NK-92-Fc-CAR.
公开/授权文献
- EP4424326A2 MODIFIED NK-92 CELLS FOR TREATING CANCER 公开/授权日:2024-09-04
信息查询